Does VEDOLIZUMAB Cause Flushing? 192 Reports in FDA Database

Q: Does VEDOLIZUMAB cause Flushing?

192 reports of Flushing have been filed with the FDA for VEDOLIZUMAB, representing 0.3% of all VEDOLIZUMAB adverse event reports.

Q: How dangerous is Flushing from VEDOLIZUMAB?

Of 192 reports, 1 (0.5%) resulted in death and 33 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Flushing have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.3% of all adverse event reports for VEDOLIZUMAB.

192

Reports of Flushing with VEDOLIZUMAB

0.3%

of all VEDOLIZUMAB reports

Deaths

Hospitalizations

How Dangerous Is Flushing From VEDOLIZUMAB?

Of the 192 reports, 1 (0.5%) resulted in death, 33 (17.2%) required hospitalization, and 4 (2.1%) were considered life-threatening.

Is Flushing Listed in the Official Label?

Yes, Flushing is listed as a known adverse reaction in the official FDA drug label for VEDOLIZUMAB.

What Other Side Effects Does VEDOLIZUMAB Cause?

Off label use (21,017) Colitis ulcerative (13,455) Crohn's disease (9,759) Drug ineffective (8,424) Diarrhoea (7,493) Abdominal pain (6,401) Fatigue (5,477) Haematochezia (5,215) Frequent bowel movements (4,527) Arthralgia (4,028)

What Other Drugs Cause Flushing?

DIMETHYL (10,681) TREPROSTINIL (3,166) TECFIDERA (2,385) AMBRISENTAN (1,741) DALFAMPRIDINE (1,605) DIROXIMEL (1,518) INFLIXIMAB (1,488) PACLITAXEL (1,397) GLATIRAMER (1,291) EPOPROSTENOL (1,256)

Which VEDOLIZUMAB Alternatives Have Lower Flushing Risk?

VEDOLIZUMAB vs VELAGLUCERASE ALFA VEDOLIZUMAB vs VELCADE VEDOLIZUMAB vs VELETRI VEDOLIZUMAB vs VELIPARIB VEDOLIZUMAB vs VEMURAFENIB

VEDOLIZUMAB Full Profile All Flushing Reports All Drugs Causing Flushing VEDOLIZUMAB Demographics